Brief: Cymabay Announces Publication Of Two-Year Safety And Efficacy Results
01/11/2023 12:04
Nov 1 (Reuters) - Cymabay Therapeutics Inc CBAY.O :
* CYMABAY ANNOUNCES PUBLICATION OF TWO-YEAR SAFETY AND
EFFICACY
RESULTS OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY
CHOLANGITIS
Source text for Eikon: ID:nGNX7bT8Dv
Further company coverage: CBAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CymaBay Therapeutics
See all newsBrief: CymaBay Says EMA Accepted For Review The Marketing Authorization Application For Seladelpar
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap